Comparison of clinical outcome and costs with CC + gonadotropins and gnrha + gonadotropins during Ivf/ICSI cycles.

about

Trends in the use of intracytoplasmatic sperm injection marked variability between countries.A short narrative review of the feasibility of adopting mild ovarian stimulation for IVF as the current standard of care.

P2860

Q37245639-02AE93DF-5F7E-43AE-AB3E-69D8BAED8F7E Q38006611-D138D161-4D28-4D63-B3B4-DB4F5DF02B87

P2860

Comparison of clinical outcome and costs with CC + gonadotropins and gnrha + gonadotropins during Ivf/ICSI cycles.

Item

http://www.wikidata.org/entity/Q36269590

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Comparison of clinical outcome ...... ropins during Ivf/ICSI cycles.

@ast

Comparison of clinical outcome ...... ropins during Ivf/ICSI cycles.

@en

type

Item

label

Comparison of clinical outcome ...... ropins during Ivf/ICSI cycles.

@ast

Comparison of clinical outcome ...... ropins during Ivf/ICSI cycles.

@en

prefLabel

Comparison of clinical outcome ...... ropins during Ivf/ICSI cycles.

@ast

Comparison of clinical outcome ...... ropins during Ivf/ICSI cycles.

@en

P1476

Comparison of clinical outcome ...... ropins during Ivf/ICSI cycles.

@en

P2093

Peter Kovacs

http://www.w3.org/2001/XMLSchema#string

Steven G Kaali

http://www.w3.org/2001/XMLSchema#string

Szabolcs Matyas

http://www.w3.org/2001/XMLSchema#string

l Artur Bernard

http://www.w3.org/2001/XMLSchema#string

P2860

Insurance coverage and outcomes of in vitro fertilization.

Clomiphene citrate: mechanism(s) and site(s) of action--a hypothesis revisited.

Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to 'friendly IVF'?

Minimal ovarian hyperstimulation for in vitro fertilization using sequential clomiphene citrate and gonadotropin with or without the addition of a gonadotropin-releasing hormone antagonist.

The use of clomiphene citrate/human menopausal gonadotrophins in conjunction with GnRH antagonist in an IVF/ICSI program is not a cost effective protocol.

The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme.

Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotrophins.

Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation.

P2888

b:jarg.0000040234.21133.35

P304

197-202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1023/B:JARG.0000040234.21133.35

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1014353272

http://www.w3.org/2001/XMLSchema#string

P698

15526974

http://www.w3.org/2001/XMLSchema#string

P932

3455227

http://www.w3.org/2001/XMLSchema#string

Comparison of clinical outcome and costs with CC + gonadotropins and gnrha + gonadotropins during Ivf/ICSI cycles.

about

P2860

P2860

Comparison of clinical outcome and costs with CC + gonadotropins and gnrha + gonadotropins during Ivf/ICSI cycles.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932